Successful Treatment of Pregnant and Postpartum Women With Severe COVID-19 Associated Acute Respiratory Distress Syndrome With Extracorporeal Membrane Oxygenation.
Jairo H BarrantesJamel OrtolevaErika R O'NeilErik E SuarezSharon Beth LarsonAniket S RaliCara AgerstrandLorenzo GrazioliSubhasis ChatterjeeMarc M AndersPublished in: ASAIO journal (American Society for Artificial Internal Organs : 1992) (2021)
There are limited data on the use of extracorporeal membrane oxygenation (ECMO) for pregnant and peripartum women with COVID-19 associated acute respiratory distress syndrome (ARDS). Pregnant women may exhibit more severe infections with COVID-19, requiring intensive care. We supported nine pregnant or peripartum women with COVID-19 ARDS with ECMO, all surviving and suffering no major complications from ECMO. Our case series demonstrates high-maternal survival rates with ECMO support in the management of COVID-19 associated severe ARDS, highlighting that these pregnant and postpartum patients should be supported with ECMO during this pandemic.
Keyphrases
- acute respiratory distress syndrome
- extracorporeal membrane oxygenation
- coronavirus disease
- sars cov
- pregnant women
- mechanical ventilation
- respiratory failure
- end stage renal disease
- respiratory syndrome coronavirus
- early onset
- chronic kidney disease
- ejection fraction
- peritoneal dialysis
- pregnancy outcomes
- body mass index
- big data
- physical activity
- artificial intelligence
- machine learning
- patient reported
- data analysis